Innova Captab logo

Innova Captab PE ratio, market cap and valuation

NSE: INNOVACAPBSE: 544067Pharmaceuticals & BiotechnologySmall Cap

Last close ₹987.30down ₹9.20 (0.92%)BSE ₹984.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹996.50.

52-week range of traded prices to 23 Oct 2026
₹622.00Low, 2 Mar 2026₹1,353.50High, 23 Sep 2026
Market cap
₹5,650 Cr828th largest listed
P/E
36.1
P/B
5.2
Dividend yield
0.20%
ROE
15.3%
ROCE
15.0%
Debt to equity
0.32
Volume, NSE
50,81148.1% delivered

Innova Captab PE ratio and valuation against its own history

Each ratio on 23 Oct 2026 beside its median over each window. The PE ratio is the market cap over the profit of the last twelve months.

  • Price to earnings36.15today

    1 year

    Median 34.80

    Today is at or above 60% of the 247 days

    3 years, since Jun 2024

    Median 38.49

    Today is at or above 33% of the 587 days

  • Price to book5.22today

    1 year

    Median 4.50

    Today is at or above 79% of the 247 days

    3 years, since Jun 2024

    Median 5.09

    Today is at or above 60% of the 587 days

  • Price to sales3.23today

    1 year

    Median 3.07

    Today is at or above 58% of the 247 days

    3 years, since Jun 2024

    Median 3.65

    Today is at or above 30% of the 587 days

  • EV to EBITDA23.08today

    1 year

    Median 22.48

    Today is at or above 56% of the 247 days

    3 years, since Jun 2024

    Median 25.93

    Today is at or above 28% of the 587 days

  • Dividend yield0.20%today

    1 year

    Median 0.20%

    Today is at or above 50% of the 247 days

    3 years, since Jan 2024

    Median 0.00%

    Today is at or above 82% of the 697 days

  • Earnings yield2.77%today

    1 year

    Median 2.87%

    Today is at or above 41% of the 247 days

    3 years, since Jun 2024

    Median 2.60%

    Today is at or above 67% of the 587 days

Each track ranks every trading day in the window from the day the ratio was lowest to the day it was highest; the dot is today. The share under it is how many of those days the ratio was at or below today's level, so a high share means today is higher than on most days in the window. A window is shown only when the ratio is held on most of its trading days; a day after a loss-making year has no P/E. Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures

The twelve months: Filed 22 Aug

  • Price to earnings =Market cap÷Net profit, last twelve months₹156 Cr
  • Price to book =Market cap÷Net worth₹1,082 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹1,749 Cr
  • Enterprise value =Market cap+Borrowings₹344 Cr−Cash₹3.87 Cr
  • EV to EBITDA =Enterprise value÷Operating profit, last twelve months₹259 Cr
  • Market cap =Close×Shares in issue5,72,24,929at 30 Sep 2026

Consolidated accounts, the twelve months to Jun 2026, balance sheet at Mar 2026, ₹ crore.Innova Captab financials ›

Innova Captab valuation at each year end

On the last trading day of each March, the month the company's year ends.Innova Captab dividend history

RatioMar 2024Mar 2025Mar 2026
Market cap (₹ crore)2,5735,0293,948
Price to earningsNo full year39.529.8
Price to bookShares changed5.63.9
Price to salesNo full year4.22.6
EV to EBITDANo full year29.819.1
Dividend yield0.00%0.00%0.29%
Earnings yieldNo full year2.5%3.4%
A ratio that does not exist on the day says why in its cell.

Innova Captab market cap, since Jan 2024

The last trading day of each month.

Market cap, ₹ crore

  • Market cap

Earnings per share, book value and enterprise value

From the close on 23 Oct 2026, with the last twelve months' results.

Enterprise value
₹5,990 Cr
P/E to growth
1.77
Earnings per share
₹27.31
Book value per share
₹188.99
Dividends, last 12 months
₹2.00
Public's market cap
₹2,774 Cr

Against Pharmaceuticals

216 listed companies in Pharmaceuticals, each priced on its last trading day; Innova Captab is 53rd among them by market cap. Each median leaves out Innova Captab itself and takes the other companies that have the figure.

Industry median P/E
28.1Across 155 other companies
Industry median P/B
2.8Across 186 other companies
Industry median EV/EBITDA
18.7Across 141 other companies
Industry median dividend yield
0.53%Across 88 other companies